These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 22398417

  • 1. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, Bauersachs R.
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [Abstract] [Full Text] [Related]

  • 2. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 3. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [Abstract] [Full Text] [Related]

  • 4. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.
    Katz DF, Maddox TM, Turakhia M, Gehi A, O'Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu JC.
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [Abstract] [Full Text] [Related]

  • 5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [Abstract] [Full Text] [Related]

  • 6. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018
    [Abstract] [Full Text] [Related]

  • 7. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ, Euro Heart Survey Investigators.
    Am Heart J; 2007 Jun 01; 153(6):1006-12. PubMed ID: 17540203
    [Abstract] [Full Text] [Related]

  • 8. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry].
    Moser J, Kuck KH, Andresen D, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Brachmann J, Lewalter T, Hochadel M, Senges J, Willems S, Hoffmann BA.
    Dtsch Med Wochenschr; 2014 Sep 01; 139(39):1923-8. PubMed ID: 25225860
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP, Saba S, Zhang Y, Hernandez I.
    J Am Heart Assoc; 2018 Jan 04; 7(1):. PubMed ID: 29301756
    [Abstract] [Full Text] [Related]

  • 10. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep 04; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 11. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar 04; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 12. Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use.
    Wilke T, Groth A, Pfannkuche M, Harks O, Fuchs A, Maywald U, Krabbe B.
    J Thromb Thrombolysis; 2015 Jul 04; 40(1):97-107. PubMed ID: 25218507
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
    Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini C, Zaccà F, Proto C, SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators.
    Int J Cardiol; 2013 Oct 12; 168(5):4729-33. PubMed ID: 23948115
    [Abstract] [Full Text] [Related]

  • 14. Stroke and bleeding risk evaluation in atrial fibrillation: results of the European heart rhythm association survey.
    Larsen TB, Potpara T, Dagres N, Pison L, Estner H, Blomström-Lundqvist C, Scientific Initiative Committee, European Heart Rhythm Association.
    Europace; 2014 May 12; 16(5):698-702. PubMed ID: 24798958
    [Abstract] [Full Text] [Related]

  • 15. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.
    Europace; 2015 Dec 12; 17(12):1777-86. PubMed ID: 26321406
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, López-Sendón J, Vardas PE, Aliot E, Santini M, Crijns HJ, Euro Heart Survey Investigators.
    Eur Heart J; 2006 Dec 12; 27(24):3018-26. PubMed ID: 16731536
    [Abstract] [Full Text] [Related]

  • 17. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A, Montoro JB, Del Blanco BG, Llavero N, Barrabés JA, Alfonso F, Bueno H, Cequier A, Serra A, Zueco J, Sabaté M, Rodríguez-Leor O, García-Dorado D.
    Am Heart J; 2013 Oct 12; 166(4):669-75. PubMed ID: 24093846
    [Abstract] [Full Text] [Related]

  • 18. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP.
    Europace; 2014 Mar 12; 16(3):308-19. PubMed ID: 24351881
    [Abstract] [Full Text] [Related]

  • 19. Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit.
    Inui TS, Parina R, Chang DC, Inui TS, Coimbra R.
    J Trauma Acute Care Surg; 2014 Mar 12; 76(3):642-9; discussion 649-50. PubMed ID: 24553530
    [Abstract] [Full Text] [Related]

  • 20. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
    Ertas F, Eren NK, Kaya H, Aribas A, Acar G, Kanadasi M, Gedik S, Oylumlu M, Yuksel M, Ulgen MS, AFTER Investigators.
    Cardiol J; 2013 Mar 12; 20(4):447-52. PubMed ID: 23677730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.